COVID-19 treatment
COVID-19 Antivirals Are No Longer Free—What Now?
HHS announced a plan to smooth the transition to traditional ordering, distribution and payment for COVID-19 ...
JANUARY 3, 2024
FDA: Gohibic Authorized for Severe COVID-19 Treatment
The FDA authorized vilobelimab injection (Gohibic, InflaRx) to treat COVID-19 in hospitalized adults.
APRIL 5, 2023
FDA: Sotrovimab Ineffective Against New Omicron Subvariant
The FDA limited the EUA for sotrovimab in parts of the United States, because the authorized dose is unlikely to be ...
MARCH 31, 2022
Load more